Mammalian TAF(II)30 is required for cell cycle progression and specific cellular differentiation programmes.

Area of Science:

• Molecular Biology
• Cell Biology
• Gene Regulation

Background:

• TATA-binding protein associated factors (TAFs) are crucial components of the TFIID complex, involved in transcription initiation.
• TAF(II)30 is a specific TAF implicated in regulating gene expression.

Purpose of the Study:

• To investigate the essentiality of TAF(II)30 in cell viability and cell cycle progression.
• To determine the role of TAF(II)30 in differentiation pathways.

Main Methods:

• Homologous recombination and Cre-loxP strategy were used to disrupt the TAF(II)30 gene in murine F9 embryonal carcinoma cells.
• Cell viability, cell cycle phase, apoptosis, protein phosphorylation, and gene expression were analyzed.
• Retinoic acid (RA) and cAMP treatments were employed to study differentiation.

Main Results:

• TAF(II)30-null cells exhibited G(1)/G(0) cell cycle arrest and apoptosis, but were rescued by human TAF(II)30 expression.
• Impaired cyclin E expression and hypophosphorylated retinoblastoma protein were observed in null cells.
• RA treatment prevented cell death and induced primitive endodermal differentiation in null cells.
• RA and cAMP-induced parietal endodermal differentiation was impaired in TAF(II)30-null cells.

Conclusions:

• TAF(II)30 is essential for the viability of F9 embryonal carcinoma cells.
• TAF(II)30 plays a critical role in regulating the G(1)/G(0) cell cycle transition and preventing apoptosis.
• TAF(II)30 is required for specific differentiation pathways, indicating its role in a subset of gene transcription.